GI Innovation CEO On Developing World’s First Microbiome-Biologics Combo

GI Innovation's drug pipeline GI301
GI Innovation's Novel Long-Acting IgE Trap -Fc Fusion Protein GI301 • Source: GI Innovation Inc.

More from South Korea

More from Focus On Asia